Cargando…
Longitudinal Follow-Up of Blood Telomere Length in HIV-Exposed Uninfected Children Having Received One Year of Lopinavir/Ritonavir or Lamivudine as Prophylaxis
Telomere shortening can be enhanced upon human immunodeficiency virus (HIV) infection and by antiretroviral (ARV) exposures. The aim of this study was to evaluate the acute and long-term effect on telomere shortening of two ARV prophylaxes, lopinavir/ritonavir (LPV/r) and lamivudine (3TC), administe...
Autores principales: | Monnin, Audrey, Vizeneux, Amélie, Nagot, Nicolas, Eymard-Duvernay, Sabrina, Meda, Nicolas, Singata-Madliki, Mandisa, Ndeezi, Grace, Tumwine, James Kashugyera, Kankasa, Chipepo, Goga, Ameena, Tylleskär, Thorkild, Van de Perre, Philippe, Molès, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468502/ https://www.ncbi.nlm.nih.gov/pubmed/34572228 http://dx.doi.org/10.3390/children8090796 |
Ejemplares similares
-
Mitochondrial DNA Parameters in Blood of Infants Receiving Lopinavir/Ritonavir or Lamivudine Prophylaxis to Prevent Breastfeeding Transmission of HIV-1
por: Monnin, Audrey, et al.
Publicado: (2020) -
Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life
por: Nagot, Nicolas, et al.
Publicado: (2021) -
Mitochondrial DNA Instability Is Common in HIV-Exposed Uninfected Newborns
por: Monnin, Audrey, et al.
Publicado: (2021) -
Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174
por: Nagot, Nicolas, et al.
Publicado: (2012) -
Health Outcomes at School Age among Children Who Are HIV-Exposed but Uninfected with Detected Mitochondrial DNA Depletion at One Year
por: Monnin, Audrey, et al.
Publicado: (2020)